Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

RNY (Roux-en-Y) gastric bypass and the gastric sleeve (sleeve gastrectomy) are two of the most common bariatric surgeries. While both procedures restrict the stomach’s size, the RNY bypass also reroutes part of the small intestine, reducing calorie absorption. The sleeve removes a large portion of the stomach without altering the intestines. The choice between the two depends on the patient’s health, goals, and surgeon recommendations.

The term bariatric refers to the branch of medicine focused on the prevention and treatment of obesity and related disorders. Bariatric procedures, such as gastric bypass or sleeve gastrectomy, are designed to help patients achieve significant, long-term weight loss when other methods like diet and exercise have failed.

The death rate for gastric sleeve surgery in Antalya is extremely low, with rates similar to those in Western countries. With advancements in laparoscopic surgery and highly trained bariatric surgeons, the mortality rate is estimated to be less than 0.1%. Most complications are manageable and arise from issues such as leaks or infections.

Non-surgical gastric sleeve alternatives, like Endoscopic Sleeve Gastroplasty (ESG), are gaining popularity in Antalya. ESG is a minimally invasive procedure where a doctor uses an endoscope to place sutures in the stomach, reducing its size without surgery. This procedure has a quicker recovery time and fewer risks compared to traditional surgery, making it an attractive option for those unable to undergo more invasive procedures.

Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

This is another term for the Roux-en-Y gastric bypass surgery, where the stomach is divided into a small pouch and a large "remnant," with the small intestine rerouted to connect to both. It is a more complex surgery compared to other weight-loss procedures but has a high success rate in achieving long-term weight loss.

A gastric infection often results from bacteria such as Helicobacter pylori (H. pylori), which causes inflammation in the stomach lining. This infection is a major cause of ulcers and, in some cases, can lead to stomach cancer. Treatment involves antibiotics to eradicate the bacteria, along with acid-reducing medications.

Patients who undergo sleeve gastrectomy in Turkey often share impressive before-and-after photos that showcase significant weight loss. Most patients lose 60-70% of their excess body weight within the first year after surgery. Turkey is well-known for delivering high-quality results at a fraction of the cost found in the UK, US, or other Western countries, making it a popular choice for those considering the surgery.

RNY reversal is the process of undoing the Roux-en-Y gastric bypass. Although rare, reversals are sometimes necessary due to complications such as malnutrition, severe dumping syndrome, or other medical issues.